bioAffinity Technologies reports 146% jump in CyPath Lung test sales

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. CRWD
4. ON
5. INSP
6. RXRX
7. VRTX
8. MTCH
9. CVI
10. CHKP

Go back to bioAffinity Technologies reports 146% jump in CyPath Lung test sales

bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026

April 1, 2026 8:00 AM EDT

Noninvasive diagnostic continues to gain traction in the current and expanding U.S. addressable market of $3.58 billion for pulmonary nodule management and surveillance of lung cancer survivors

Flow cytometry+AI technology has potential to improve lung cancer risk assessment and nodule management

SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc.... More